Post‐Hematopoietic Stem Cell Transplantation Eczematous Dermatitis Spectrum Successfully Treated With Dupilumab: A Case Series and Review of the Literature

医学 湿疹性皮炎 皮肤病科 杜皮鲁玛 移植 特应性皮炎 接触性皮炎 过敏性接触性皮炎 广谱 尿布皮炎
作者
Belén Rodríguez Sánchez,Minia Campos‐Domínguez,Antonio Alcalá Ramírez Del Puerto,José Bernabéu‐Wittel,M.T. Monserrat-García,Francisco Arias‐Lotto,Verónica Parra‐Blanco,Cristina Beléndez‐Bieler,Marina García‐Morín,Eduardo J. Bardón-Cancho,José Manuel Marco-Sánchez,Alba González‐Gerrero,Eulàlia Baselga,Carolina Prat Torres
出处
期刊:Pediatric Dermatology [Wiley]
卷期号:43 (2): 289-299 被引量:1
标识
DOI:10.1111/pde.70084
摘要

BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is associated with several dermatological adverse events, including the de novo onset of pruritus and eczema. Some authors consider this a variant of graft-versus-host disease (GvHD) and refer to it as eczematous or atopic dermatitis (AD)-like GvHD, while others categorize it separately as eczematous or AD-like dermatitis. This study aimed to report a pediatric case series and review previously published cases treated with dupilumab. METHODS: Retrospective multicenter study including patients aged 0-18 treated with dupilumab for new eczematous lesions following HSCT up to 2024 in three tertiary hospitals in Spain. A literature review in PubMed identified all reported pediatric and adult cases. RESULTS: A total of 24 cases were identified: 9 from our centers and 15 from the literature. Median onset was 3 months post-HSCT. All patients presented with pruritus and eczema. 47% showed flexural involvement. Histology revealed eczematous features in 73%, mixed GvHD/eczema in 20%, and pure GvHD in 7%. 38% were classified as post-HSCT eczema, and 63% as eczematous or AD-like GvHD. All were refractory to topical corticoids and different systemic immunosuppressants. Dupilumab led to complete or near-complete resolution in 96% of cases. No serious adverse events were reported. CONCLUSION: Dupilumab appears to be effective and safe for eczematous lesions occurring after HSCT, regardless of whether the histopathological characteristics align with eczema or GvHD. This supports a shared spectrum between eczematous dermatitis and GvHD, and the use of a neutral diagnostic term. Further research is needed to clarify its pathogenesis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
3秒前
周末完成签到,获得积分10
3秒前
4秒前
orixero的应助被科研通管家采纳,获得10
5秒前
Jasper的应助被科研通管家采纳,获得10
5秒前
daomaihu发布了新的文献求助100
5秒前
乐空思的应助被科研通管家采纳,获得30
5秒前
无极微光的应助被科研通管家采纳,获得20
5秒前
汉堡包的应助被科研通管家采纳,获得10
5秒前
5秒前
科目三的应助被科研通管家采纳,获得10
5秒前
6秒前
脑洞疼的应助被科研通管家采纳,获得10
6秒前
深情安青的应助被科研通管家采纳,获得10
6秒前
科研小白给科研小白的求助进行了留言
6秒前
李爱国的应助被科研通管家采纳,获得10
6秒前
6秒前
zq123完成签到,获得积分10
6秒前
6秒前
斯文败类的应助被科研蚂蚁采纳,获得10
6秒前
wanci的应助被科研通管家采纳,获得10
6秒前
6秒前
哈哈哈发布了新的文献求助10
7秒前
花随幽人落完成签到,获得积分10
7秒前
扎克斯完成签到,获得积分10
7秒前
科研通AI6.2的应助被Lila采纳,获得10
8秒前
8秒前
Buster发布了新的文献求助10
8秒前
e00ec发布了新的文献求助10
8秒前
coolru的应助被constanceFR采纳,获得10
8秒前
xiaole完成签到,获得积分10
8秒前
wangbq完成签到 ,获得积分10
9秒前
胖胖完成签到,获得积分10
9秒前
11秒前
欣喜香菇发布了新的文献求助10
11秒前
忧虑的牛排完成签到,获得积分10
12秒前
机灵奇迹完成签到,获得积分10
12秒前
别摆烂了完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175267
求助须知:如何正确求助?哪些是违规求助? 9567035
关于积分的说明 21789830
捐赠科研通 7769741
什么是DOI,文献DOI怎么找? 3431840
关于科研通互助平台的介绍 2556149
邀请新用户注册赠送积分活动 2477241